Linagliptin-metformin


( Last Updated : March 8, 2013)
Generic Name:
Linagliptin-metformin
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, type 2
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Call for patient/clinician input open:
Brand Name:
Jentadueto
Project Line:
Reimbursement Review
Project Number:
SR0306-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Diabetes mellitus (Type 2)
Recommendation Type:
List with criteria/condition
Final Recommendation: